Home 2023

Ethics, law and policy

Icahn Sues Illumina’s Ex-CEO, Board, Alleging Breach of Duty
GEN Edge

Icahn Sues Illumina’s Ex-CEO, Board, Alleging Breach of Duty

Alex Philippidis -
0
Illumina Links Grail Divestiture to Losing European Or U.S. Appeals
Industry News

Illumina Links Grail Divestiture to Losing European Or U.S. Appeals

Alex Philippidis -
0
Meeting on the Mesa: Without Ethics, Cell and Gene Therapy Will Fail
Drug Discovery

Meeting on the Mesa: Without Ethics, Cell and Gene Therapy Will Fail

Jonathan D Grinstein, PhD -
0
European Commission Orders Illumina to Divest of Grail
Industry News

European Commission Orders Illumina to Divest of Grail

Alex Philippidis -
0
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Drug Discovery

Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb

Alex Philippidis -
0
After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?
Drug Discovery

After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?

Uduak Thomas -
0
Mixed-Mode Chromatography
Bioprocessing

Mixed-Mode Chromatography

John Sterling -
0
Digital Tech as a CDMO Differentiator
Bioprocessing

Digital Tech as a CDMO Differentiator

John Sterling -
0
Analyzing and Minimizing Host-Cell Proteins
Bioprocessing

Analyzing and Minimizing Host-Cell Proteins

John Sterling -
0
Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale
Artificial Intelligence

Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale

Jonathan D Grinstein, PhD -
0
123...110Page 1 of 110
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.